메뉴 건너뛰기




Volumn 162, Issue 4, 2005, Pages 814-815

Pramipexole, ropinirole, and mania in Parkinson's disease [9]

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; RECEPTOR SUBTYPE; ROPINIROLE; SELEGILINE;

EID: 16844362279     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (37)

References (3)
  • 1
    • 0031564659 scopus 로고    scopus 로고
    • The behavioural effects of pramipexole, a novel dopamine receptor agonist
    • Maj J, Rogoz Z, Skuza G, Kolodziejczyk K: The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol 1997; 324:31-37
    • (1997) Eur J Pharmacol , vol.324 , pp. 31-37
    • Maj, J.1    Rogoz, Z.2    Skuza, G.3    Kolodziejczyk, K.4
  • 2
    • 0030867369 scopus 로고    scopus 로고
    • The mesolimbic dopamine system as a target for rapid antidepressant action
    • Willner P: The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997; 12(3 suppl):S7-S14
    • (1997) Int Clin Psychopharmacol , vol.12 , Issue.3 SUPPL.
    • Willner, P.1
  • 3
    • 1542313961 scopus 로고    scopus 로고
    • Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
    • Goldberg JF, Burdick KE, Endick CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004; 161:564-566
    • (2004) Am J Psychiatry , vol.161 , pp. 564-566
    • Goldberg, J.F.1    Burdick, K.E.2    Endick, C.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.